The Psychedelic Lineage
Ancient ceremony, modern science, and the return of non-ordinary states to clinical practice
Humans have used psychoactive substances for healing and spiritual transformation for millennia. The modern clinical lineage begins with Albert Hofmann's synthesis of LSD in 1938, and the first wave of research (1950s–60s) that produced over a thousand published papers and remarkable clinical results for alcoholism, depression, and end-of-life anxiety. The backlash — driven by cultural panic, the counterculture, and political pressure — shut research down for decades. The renaissance, beginning in the late 1990s at Johns Hopkins, NYU, Imperial College London, and MAPS, has produced some of the most striking results in contemporary psychiatry. This lineage raises fundamental questions about consciousness, healing, and the relationship between pharmacology and psychotherapy.
Full Contents
-
Indigenous & Ancient Use
Psilocybin mushrooms, ayahuasca, peyote, iboga, San Pedro cactus, and other plant medicines have been used in indigenous ceremonial contexts for thousands of years — for healing, divination, initiation, and spiritual communion. These are not "preclinical" uses; they are sophisticated healing technologies with their own frameworks.
Concepts: Set and setting (indigenous origins) · Ceremony and container · Plant teachers / plant spirits · Community integration · Initiation and transformation
-
William James & Aldous Huxley
James's "Varieties of Religious Experience" (1902) legitimized the study of mystical and altered states within academic psychology. Huxley's "The Doors of Perception" (1954) — his account of mescaline — brought psychedelic experience into intellectual discourse. Both argued that ordinary waking consciousness is only one type of consciousness among many.
Concepts: Varieties of religious experience · The doors of perception · Mystical experience · Perennial philosophy · Reducing valve theory of consciousness
Relation: James and Huxley provided the philosophical legitimacy for taking altered states seriously. James's pragmatism asked: if the experience transforms the person, does the mechanism matter? This question remains central to the field.
-
Albert Hofmann & LSD
Synthesized LSD-25 at Sandoz in 1938; discovered its psychoactive properties through accidental exposure in 1943. Called it his "problem child." Hofmann viewed LSD as a tool for consciousness research and spiritual exploration, not recreational use.
Concepts: LSD (lysergic acid diethylamide) · Bicycle Day (April 19, 1943) · Psychotomimetic model (early — LSD mimics psychosis) · Consciousness research tool
-
Stanislav & Christina Grof / Holotropic Breathwork
When LSD became illegal, Grof developed Holotropic Breathwork — using accelerated breathing, evocative music, and bodywork to access non-ordinary states without substances. Based on decades of LSD research, it preserved the cartography of inner experience while making it legally accessible.
Concepts: Holotropic states · COEX systems · Perinatal matrices · Transpersonal experiences · Inner healing intelligence · Mandala drawing
Relation: Grof bridges the first wave and the renaissance. His experiential maps — biographical, perinatal, and transpersonal domains — inform how many contemporary therapists understand psychedelic experiences. Holotropic Breathwork kept the clinical knowledge alive during prohibition.
-
First Wave Research
Over 1,000 papers published. Two models emerged: psycholytic (low-dose, multiple sessions, psychodynamic framework — European) and psychedelic (high-dose, single transformative experience — North American). Remarkable results for alcoholism, end-of-life anxiety, and depression. Grof mapped the phenomenology of non-ordinary states across thousands of sessions.
Concepts: Psycholytic vs. psychedelic therapy · Perinatal matrices (Grof) · Systems of Condensed Experience (COEX) · Transpersonal experiences · Ego dissolution
Relation: The first wave showed extraordinary clinical potential but lacked methodological rigor by today's standards (no randomization, limited controls). Grof's work was the most systematic — his maps of psychedelic experience remain influential even as the field moves toward manualized protocols.
-
The Shutdown
LSD became a symbol of the counterculture. Leary's "turn on, tune in, drop out" terrified the establishment. Scheduling of LSD (1970), psilocybin, mescaline, and later MDMA (1985) effectively ended clinical research for decades. The scientific baby was thrown out with the countercultural bathwater.
Concepts: Schedule I classification · Moral panic · Loss of research infrastructure · Underground therapy continued · MAPS founded (1986)
Relation: The shutdown was political, not scientific. The research evidence was promising; the cultural context was threatening. Rick Doblin founded MAPS in 1986 specifically to navigate the regulatory path back to legal psychedelic therapy — a project that took 35 years.
-
MAPS & MDMA-Assisted Therapy
MAPS (Multidisciplinary Association for Psychedelic Studies) spent 35 years navigating the regulatory path for MDMA-assisted therapy for PTSD. Phase 3 trials showed unprecedented effect sizes. MDMA enhances empathy, reduces fear, and opens a therapeutic window for trauma processing. FDA advisory committee review in 2024 was controversial.
Concepts: MDMA as empathogen · Inner healing intelligence · Therapeutic window · Three preparatory + three medicine + nine integration sessions · Non-directive support
Relation: MDMA-assisted therapy is the most researched psychedelic treatment and was closest to FDA approval. The Mithoefer protocol combines non-directive, trust-based support with MDMA's pharmacological effects. The FDA advisory committee raised concerns about methodology and blinding — the field is still navigating this.
-
Psilocybin Research
Johns Hopkins (Griffiths), Imperial College London (Carhart-Harris), and NYU (Ross) led the psilocybin renaissance. Griffiths's 2006 study on mystical experience in healthy volunteers was the landmark. Subsequent trials for depression, end-of-life distress, addiction, and OCD have shown remarkable results.
Concepts: Mystical-type experience · Ego dissolution · Psychological flexibility · Default mode network disruption · Entropic brain hypothesis · Emotional breakthrough
Relation: Carhart-Harris's "entropic brain hypothesis" provides the leading neuroscientific model: psychedelics increase neural entropy, disrupting rigid patterns (the default mode network) and allowing new configurations. This may explain both the subjective experience and the therapeutic mechanism.
-
Ketamine-Assisted Psychotherapy
Ketamine — an anesthetic already legal and widely used — became the first legally available psychedelic-adjacent therapy. KAP combines sub-anesthetic ketamine with psychotherapeutic support. Different from IV ketamine clinics (which focus on pharmacology without therapy).
Concepts: Dissociative state · NMDA receptor antagonism · Neuroplasticity window · Psychotherapeutic integration · Intention setting
Relation: KAP occupies a unique position: it's legally available now, doesn't require special regulatory approval, and provides a dissociative rather than classical psychedelic experience. It's both a treatment in its own right and a training ground for therapists preparing for psilocybin and MDMA.
-
Integration & Harm Reduction
Integration — the process of making meaning of psychedelic experiences and incorporating insights into daily life — is increasingly recognized as the therapeutic core. PHRI (Psychedelic Harm Reduction & Integration) provides support for people who have had difficult psychedelic experiences. Fireside Project offers a peer support line for people during or after psychedelic experiences.
Concepts: Integration · Difficult experiences (not "bad trips") · Harm reduction · Spiritual emergency · Preparation, experience, integration
Relation: The recognition that the experience itself is not the therapy — integration is — echoes Janet's phase model and Herman's reconnection stage. The psychedelic experience opens a door; integration determines whether the person walks through it. PSIP takes a different position: the therapeutic work happens during the medicine state itself through active relational engagement with somatic defense cascades, not primarily through post-session integration.
-
EMBARK
A transdiagnostic, pan-psychedelic clinical framework. Six domains: Existential-Spiritual, Mindfulness, Body-Aware, Relational, Keeping Momentum, and Awareness. Designed to be adaptable across substances and clinical populations. Developed for the NYU psilocybin trials.
Concepts: Six clinical domains · Pan-psychedelic framework · Transdiagnostic · Preparation → medicine session → integration · Therapist competencies
Relation: EMBARK represents the field's move toward manualized, trainable frameworks. It integrates elements from multiple therapeutic traditions (existential, somatic, relational, mindfulness) into a coherent model for psychedelic-assisted therapy.